36 results were returned
Bird & Bird LLP has advised Pfizer on the global spin-off and merger of its Upjohn business with Mylan N.V. to form the new global pharmaceutical company with the name Viatris Inc.
International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...
We were successful in defending our clients in a major Supplementary Protection Certificate (SPC) case.
If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...
In the wake of the COVID-19 pandemic the German government has recently passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, the ...
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).
As the number of vaccinated people continues to rise, the question of special rights may become more pressing, at least in the private sector. The basic rule under German law is that anyone who allows other people ...
DEFAULT DEFAULT Most Relevant Alphabetical Chronological Go
REFINE RESULTS: